Moreover, AZ1 treatment significantly induced cell death and reduced viability in a dose-dependent manner, especially in CLL cells harboring NOTCH1 mutations (Fig. 8). Here, NOTCH1 is linked to B-cell chronic lymphocytic leukemia.